[½ÅÀÔ/°æ·Â] RA (Regulatory Affairs) ¸ðÁý |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
- Çѵ¶ º»»ç (¼¿ï½Ã °³²±¸ Å×Çì¶õ·Î 132)
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
- ÁÖ¿ä ÀǾàÇ° Ç°¸ñ¿¡ ´ëÇØ Àü·«ÀûÀ¸·Î µî·Ï °èȹÀ» ¼ö¸³ÇÏ°í À̸¦ ½ÇÇàÇÏ¿© ¸ñÇ¥ÇÑ ½Ã°£ ³»¿¡ ÃÖ¼±ÀÇ »çÇ×À¸·Î Ç°¸ñ Çã°¡(¶Ç´Â Çã°¡ º¯°æ), ÀÓ»ó½ÃÇè°èȹ½ÂÀÎÀ» µæÇÔ
- ÀǾàÇ°ÀÇ ½Å±Ô Çã°¡, Çã°¡ º¯°æ ¶Ç´Â ±¹³» ÀÓ»ó ½ÃÇè ½ÂÀÎÀ» ¹Þ±â À§ÇÑ ÀÏÁ¤À» ¼¼¿ì°í, ¿ä±¸µÇ´Â ÀڷḦ ÀÛ¼ºÇÏ¿© ½ÅûÇÏ°í, ÃÖ¼±ÀÇ Çã°¡»çÇ× µîÀ» ȹµæÇϵµ·Ï ½Ä¾àó µî °ü·Ã±â°ü°ú »óÈ£ÀÛ¿ëÇϸç, ÀÏÁ¤ ¹× ÁøÇà»óȲ µî¿¡ ´ëÇÑ Á¤º¸¸¦ °ü·Ã ºÎ¼ µî¿¡ °øÀ¯µÇµµ·Ï Å뺸Çϸç, °ü·ÃÀڷḦ ±â·ÏÇÏ°í º¸°üÇÔ..
- ÀáÀçÀû ¹®Á¦Á¡¿¡ ´ëÇØ ¹Ì¸® ÆľÇÇÏ°í ¸Å´ÏÀú¿Í »óÀÇÇÏ¿© ¹æ¾ÈÀ» ¸ð»öÇÏ°í ´ëóÇÔ.
- µµÀÔ ¶Ç´Â °³¹ß °ËÅäÁßÀÎ Á¦Ç°/ÇÁ·ÎÁ§Æ®¿¡ ´ëÇØ ÇâÈÄ ¹ý±Ô °³Á¤ µîÀ» °í·ÁÇÏ¿© µî·Ï°¡´É¼ºÀ» °ËÅäÇÏ°í ÀûÀýÇÑ µî·ÏÀÏÁ¤À» ¼ö¸³ÇÔ
- ±¹³»¿¡¼ ÀǾàÇ°ÀÇ µî·Ï °¡´É¼º ¹× ¿ä°ÇÀ» °ËÅäÇÏ°í °ü·ÃºÎ¼¿¡ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÔ.
- ¾à»ç¹ý¿¡¼ ¿ä±¸µÇ´Â »çÇ׵鿡 ÀûÀýÈ÷ ´ëóÇÏ¿© regulatory compliance¸¦ À¯ÁöÇÏ°í business¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ ÃÖ¼ÒÈ µÇµµ·Ï °ü¸®ÇÔ.
- ¾à»ç °ü·Ã¹ý±Ô¿Í °ü·ÃÇÑ Çؼ® ¹× ÀÚ¹®À» Á¦°ø
- ¾à»ç°ü·Ã¹ý±ÔÀÇ Á¦°³Á¤ ³»¿ëÀ» ¼öÁýÇÏ°í À̵éÀÌ È¸»ç¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ¿© °ü·Ã ºÎ¼¿Í °øÀ¯ÇÏ°í ´ëÀÀÃ¥À» ¸¶·ÃÇϰųª ȸ»ç Â÷¿øÀÇ ÀÇ°ßÀ» ¼ö·ÅÇÏ¿© Á¦Ãâ
- Business¿¡ ¹®Á¦°¡ »ý±âÁö ¾Êµµ·Ï ÇÊ¿äÇÑ º¯°æÇã°¡ µîÀ» °èȹÇÏ°í ÁøÇà
- Ç°¸ñÇã°¡ °»½Å/¿¬Â÷º¸°í µî °ü¸®
|
Áö¿øÀÚ°Ý |
- ±³À°¼öÁØ Education: ¾àÇÐ ¶Ç´Â ÈÇÐ, »ý¹° °ü·Ã Çлç ÇÐÀ§ º¸À¯ÀÚ (¾à»ç ¸éÇã ¼ÒÀ¯ÀÚ ¿ì´ë)
- °æÇè & Áö½Ä Experience & knowledge:
- ÀǾàÇ°(¹ÙÀÌ¿À ÀǾàÇ° Æ÷ÇÔ)ÀÇ ÀÛ¿ë ±âÀü ¹× Á¦Ç° °ü·Ã Áö½ÄÀÇ ÀÌÇØ
- CTD µî Çã°¡ÀÚ·á¿¡ ´ëÇÑ ÀÌÇØ
- ¾à»ç ¹ý±Ô ¹× ÀǾàÇ° °ü·Ã ±ÔÁ¤, °¡À̵å¶óÀο¡ ´ëÇÑ ÀÌÇØ
- ÀÓ»ó/¾à°¡/QC.QA/MKTG/SCM °ü·Ã ¾÷¹« ÀÌÇØ
- ÄÄÇ»ÅÍ È°¿ë ´É·Â(ÇѱÛ, MS Office, ÀÎÅÍ³Ý °Ë»ö µî)
- ¿µ¾î Àбâ/¾²±â/¸»ÇÏ±â µî ¿øÈ°ÇÑ ¿µ¾î communication
- Çٽɿª·® / ½ºÅ³ Core competencies /skills:
- ¾à»ç¹ý±Ô ¹× ÀǾàÇ° °ü·Ã ±ÔÁ¤/°¡À̵å¶óÀÎ ¿¡ ´ëÇÑ ÀÌÇØ ¹× ÀÀ¿ë
- Á¦Ç° ¹× Áúº´°ü·Ã Áö½Ä
- °èȹ¼ö¸³°ú ÇÁ·ÎÁ§Æ® °ü¸®
- Çã°¡ ¼·ùÀÇ ÀÛ¼º
- ¹®Á¦ ÇØ°á
- È¿°úÀû ´ëÀΰü°è ¹× Ä¿¹Â´ÏÄÉÀ̼Ç
|
|
[°æ·Â] ºñ´¢±â Àü¹®ÀǾàÇ° Marketing |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
- Çѵ¶ º»»ç (¼¿ï½Ã °³²±¸ Å×Çì¶õ·Î 132)
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
Àü¹®ÀǾàÇ° ºñ´¢±â Áúȯ Á¦Ç°_Åäºñ¾ÖÁî, ½Ã¾Ë¸®½º À» ´ã´çÇÏ´Â PCQE (Primary Care Quality of life Enhancement) Marketing
[Àü¹®ÀǾàÇ°] Á¦Ç° - Àü¹®ÀǾàÇ° | Çѵ¶ (handok.co.kr)
- Marketing planning£¦implementation
- Resource allocation: Products mix against targets, A£¦P allocation efficiency
- Long-term franchise strategy and planning: portfolio growth, alliance/business partnership
- Timely report the supervisor according to objectives mutually agreed upon from year-to-year.
- Take a ownership of specific brand performance measures
- Perform developmental project base such as secondary market research, data analysis and etc.
- Conduct a variety of administrative functions such as medical legal mark-ups, material development, clinical study utilization£¦field force communication, all essential to the day to day operation of the brand
- Key customer management :
- Regular visit to target physicians
- Provide physicians with updated highly scientific information on product£¦disease
- Shape physicians¡¯ view on the disease and establish need for product
- Scientific program support
- Develop key speakers to become strong advocates for the product£¦therapeutic class
- Lead scientific initiatives to build clinical evident and implement medical programs
- Search£¦provide updated articles on the product and develop key message
- Deliver MR product training
- People, Capabilities, and Management:
- Talent acquisition
- Responsible for compliance with all legal requirements of company policies and ensure strict compliance
|
Áö¿øÀÚ°Ý |
- Àü¹®ÀǾàÇ° ¸¶ÄÉÆà °æ·Â 3³â ÀÌ»ó (Urology Á¦Ç° °æÇè ¿ì´ë)
- MR ¿µ¾÷ °æÇè º¸À¯ÀÚ ¿ì´ë
- ÇØ¿Ü ÆÄÆ®³Ê»ç¿Í ¿øÈ°ÇÑ ¼ÒÅëÀÌ °¡´ÉÇÑ ¿µ¾î ¼öÁØ
- Multi-National Company °æÇè º¸À¯ÀÚ ¿ì´ë
|
|
[°æ·Â] ¸¸¼ºÁúȯ MSL(Medical Science Liaison) Manager |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
Çѵ¶ MSL manager´Â ÀÇÇкÎÀÇ ÀÏ¿øÀ¸·Î¼, °úÇÐÀû ±Ù°Å¸¦ ±â¹ÝÀ¸·Î Á¦Ç°ÀÇ ¿Ã¹Ù¸¥ °¡Ä¡(value) ¸¦ ã¾Æ³»°í, À̸¦ °´°üÀûÀÌ°í ±ÕÇüÀâÈù ¹æ½ÄÀ¸·Î °í°´¿¡°Ô Àü´Þ,¼ÒÅë,±³·ùÇÔÀ¸·Î½á ÁøÁ¤ÇÑ È¯ÀÚ Á߽ɼº (Patient centricity)À» ±¸ÇöÇÔÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù.
MSL Manager´Â ´ÙÀ½°ú °°Àº ¿ªÇÒ°ú Ã¥ÀÓÀÌ ÀÖ´Ù.
- MSL ¾÷¹« ÄÚĪ ¹× ¼ºÀå ¹ßÀüÀ» Áö¿øÇÔ
- ÀÇÇкÎÀÇ Medical Strategy & Plan ¼ö¸³ ¹× ¹æÇ⼺ Á¦½Ã
- È¿°úÀûÀÎ MTL (Medical Thought Leader) Engagement
- ÀÓ»ó ¿¬±¸ÀÇ È¿À²Àû °ü¸® ¹× Áö¿ø
- °ü·Ã Á¦Ç° ¹× Áúȯ¿¡ ´ëÇÑ ÀÇÇÐ ±³À° Áö¿ø
|
Áö¿øÀÚ°Ý |
Çѵ¶ MSL Manager´Â Àü¹®¼ºÀ» ¹ÙÅÁÀ¸·Î ÆÀ¿øÀÎ MSLÀÇ ¸ð¹üÀÌ µÇ¾î¾ß ÇÏ°í ³»ºÎ ¹× ¿ÜºÎ °í°´À¸·ÎºÎÅÍ ½Å·Ú¹Þ´Â ÆÄÆ®³Ê°¡ µÇ¾î¾ß ÇÑ´Ù. .
MSL ManagerÀÇ ÀÚ°Ý ¿ä°Ç
- MSL °æ·Â 5³â ÀÌ»ó
- people management °æ·Â ¿ì´ë
- ¾à»ç ȤÀº À¯°üÇаú (»ý¹°ÇÐ, »ý¸í°úÇÐ µî) Á¹¾÷ÀÚ ¼±È£
MSL Manager ÀÇ Çʼö Á¶°Ç/¿ª·®
- ÀÇÇкÎÀÇ ºñÀü ¹× Àü·« ¼ö¸³, ¹æÇ⼺ Á¦½Ã
- È¿°úÀûÀÎ ÆÀ¿ø ÄÚĪ ¹× Çǵå¹é ½ºÅ³,
- °í°´°úÀÇ È¿°úÀûÀÎ ÀÇ»ç¼ÒÅë ´É·Â ¹× °í°´ÁöÇâ ¸¶Àεå
- Research; ÀÓ»ó ¿¬±¸ µðÀÚÀÎ ¹× °á°ú Çؼ® ´É·Â
- ´Ù¾ç¼º¿¡ ´ëÇÑ Æ÷¿ë·Â ¹× °ø°¨´É·Â
|
|
[°æ·Â] ±³Á¤/SCADA ´ã´çÀÚ |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
- »ý»êÀåºñ ¸ð´ÏÅ͸µ/Á¦¾î ½Ã½ºÅÛ(SCADA) ÇÁ·Î±×·¥ À¯Áö°ü¸®
- Global GMP ±ÔÁ¤¿¡ µû¸¥ ±³Á¤ °ü¸®
- »ý»ê ¹× QC ¼³ºñ °èÃø±â ±³Á¤ ¹× ¿Âµµ¸ÊÇÎ
- SOP ¹× GMP ¹®¼ÀÇ ÀÛ¼º ¹× °ü¸®
|
Áö¿øÀÚ°Ý |
- Àü±â °ü·Ã Àü°ø 2³âÁ¦ ÃÊ´ëÁ¹ ÀÌ»ó Á¹¾÷ÀÚ
- PLC ¹× SCADA ÇÁ·Î±×·¥ È°¿ë °¡´ÉÀÚ
- MS Office »ç¿ë °¡´ÉÀÚ(¿¢¼¿,¿öµå,ÆÄ¿öÆ÷ÀÎÆ®)
- ±àÁ¤ÀûÀÎ ¸¶Àεå¿Í Ã¥ÀÓ°¨À» °¡Áö°í ¼ÒÅëÇÒ ¼ö ÀÖ´Â ºÐ
- ¿ì´ë»çÇ×
- PLC, SCADA ÇÁ·Î±×·¥ À¯Áö°ü¸® °æ·ÂÀÚ
- ÆÄÀÌ½ã µî ºòµ¥ÀÌÅÍ ºÐ¼® ÇÁ·Î±×·¥ °æÇèÀÚ
- Àü±â°ü·Ã ÀÚ°ÝÁõ ¼ÒÁöÀÚ
|
|
[°æ·Â] Life Science½Ç Marketing |
°ø°í¸¶°¨ÀÏ |
- ä¿ë½Ã±îÁö ¸ðÁý (1Â÷ ¼·ù¸¶°¨ 2024/10/13)
|
±Ù¹«Áö |
- Çѵ¶ º»»ç (¼¿ï½Ã °³²±¸ Å×Çì¶õ·Î 132)
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
- ºê·£µå»ç (QIAGEN/ EPPENDORF/ Cellsafe/ Advanced Instrument) PO °ü¸®, ¸¶ÄÉÆà Àü·« ¼ö¸³, È«º¸ È°µ¿, Á¦Ç°±³À°
- ºê·£µå»ç ¹× ¿µ¾÷»ç¿ø, ³»ºÎ À¯°üºÎ¼¿ÍÀÇ ¿øÈ°ÇÑ Communication
- ¸¶ÄÉÆà ¿¹»ê Planning, ÁýÇà ¹× °ü¸®
- ½ÃÀå µ¿Çâ ¹× °æÀï»ç Á¤º¸¸¦ ÅëÇÑ ¸¶ÄÏ ºÐ¼®
- ½Å±Ô ºê·£µå °³¹ß
|
Áö¿øÀÚ°Ý |
- 4³âÁ¦ ´ëÇÐ ÀÌ»ó (»ý¸í°øÇÐ, »ý¹°ÇÐ, ÀÇ»ý¸í°úÇаú µî °ü·Ã Àü°ø ¹× °ü·Ã ¼®»ç ¿ì´ë)
- µ¿Á¾ ¾÷°è 4³â ÀÌ»ó °æ·Â º¸À¯ÀÚ
- ¿Ü±¹°è ÆÄÆ®³Ê»ç¿Í ±âº»ÀûÀÎ ¿µ¾î ÀÇ»ç¼ÒÅë °¡´ÉÀÚ (¿µ¾î Speaking Test ÁøÇà)
- ¿îÀü¸éÇã ÀÚ°ÝÁõ º¸À¯ÀÚ (2Á¾ º¸Åë ÀÌ»ó)
|
|
[°æ·Â] ´ç´¢/¼øȯ±â Àü¹®ÀǾàÇ° Marketing |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
- Çѵ¶ º»»ç (¼¿ï½Ã °³²±¸ Å×Çì¶õ·Î 132)
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
Àü¹®ÀǾàÇ° ¼øȯ±â ¿µ¿ªÀÇ Á¦Ç°À» ´ã´çÇÏ´Â Marketing
[Çѵ¶ Àü¹®ÀǾàÇ°]https://www.handok.co.kr/product/list/001/
- Marketing planning & implementation
- Resource allocation: Products mix against targets, A&P allocation efficiency
- Long-term franchise strategy and planning: portfolio growth, alliance/business partnership
- Timely report the supervisor according to objectives mutually agreed upon from year-to-year.
- Take a ownership of specific brand performance measures
- Perform developmental project base such as secondary market research, data analysis and etc.
- Conduct a variety of administrative functions such as medical legal mark-ups, material development, clinical study utilization & field force communication, all essential to the day to day operation of the brand
- Key customer management :
- Regular visit to target physicians
- Provide physicians with updated highly scientific information on product & disease
- Shape physicians¡¯ view on the disease and establish need for product
- Scientific program support
- Develop key speakers to become strong advocates for the product & therapeutic class
- Lead scientific initiatives to build clinical evident and implement medical programs
- Search & provide updated articles on the product and develop key message
- Deliver MR product training
- People, Capabilities, and Management:
- Talent acquisition
- Responsible for compliance with all legal requirements of company policies and ensure strict compliance
|
Áö¿øÀÚ°Ý |
- More than 3 years marketing experience : Must
- Commercial experience of Cardiovascular field in pharmaceutical firm : preferred
- Intermediate English communication/Presentation skill
- High level communication skills
- Proven project management skill (in the planning and new business case) : Understanding of P&L analysis
- Creative and innovative approaches to problem solving
- Strategic orientation
- Pro-activity and willingness to initiative
- Ability to foster and manage productive biz relationship with external stakeholders
|
|
[Çѵ¶Á¦¼®Àç´Ü] Àç´Ü¿î¿µ ¹× Àü½Ã±âȹ ´ã´çÀÚ |
°ø°í¸¶°¨ÀÏ |
|
±Ù¹«Áö |
- Çѵ¶ º»»ç (¼¿ï½Ã °³²±¸ Å×Çì¶õ·Î)
|
°æ·Â±¸ºÐ |
|
Á÷¹«»ó¼¼ |
[¸ðÁýºÎ¹®¼³¸í]
ºñ¿µ¸® °øÀ͹ýÀÎÀÎ Çѵ¶Á¦¼®Àç´ÜÀº (ÁÖ)Çѵ¶°ú â¾÷ÁÖ Íº ±è½Å±Ç ȸÀå´ÔÀÇ ±âºÎ¸¦ ¹ÙÅÁÀ¸·Î ±â¾÷ÀÇ »çȸÀû Ã¥ÀÓÀ» ´ÙÇϱâ À§ÇØ 2006³â 3¿ù Ãâ¹üÇÏ¿´½À´Ï´Ù.
1964³â °³°üÇÑ Çѵ¶ÀǾà¹Ú¹°°üÀ» ÆíÀÔÇÏ¿© ÀǾàÇÐ ºÐ¾ßÀÇ ¿ª»ç¸¦ ¾Ë¸®±â À§ÇÑ Çѵ¶ÀǾà¹Ú¹°°ü ¿î¿µ, ÀǾàÇÐ ºÐ¾ß ÀåÇÐ ¹× ¿¬±¸ Áö¿ø, Áúº´ÅðÄ¡ ¹× ¼Ò¿Ü°èÃþ Áö¿ø»ç¾÷ µî ´Ù¾çÇÑ °øÀÍ»ç¾÷À» ÆîÄ¡°í ÀÖ½À´Ï´Ù.
- ¹Ú¹°°ü ¿î¿µ °ü·Ã ¾÷¹« : Çѵ¶ÀǾà¹Ú¹°°ü ¼¿ï ¿î¿µ, ±âȹ, È«º¸, ´º½º·¹ÅÍ ¹ßÇà µî
- Àü½Ã ¹× °ø¿¬±âȹ : »ý¸í°¶·¯¸® Çö´ë ¹Ì¼ú ±âȹÀü½Ã, ¿¬ 1ȸ ÀÌ»ó ¸Þ¼¼³ª ¿¬°è ÄܼƮ ±âȹ ¹× ¿î¿µ
- ÀǾà´ë ÀåÇлý ¹× ÀǾàÇÐ ¿¬±¸Áö¿ø »ç¾÷ ¿î¿µ
- °øÀ͹ýÀÎ ¿î¿µ °ü·Ã ¾÷¹«(¿¹»ê Æí¼º ¹× ÁýÇà, ±âºÎ±Ý °ü¸®, Àç´Ü ÀÌ»çȸ ¿î¿µ µî)
- Çѵ¶ ±â¾÷»çȸ°øÇåÆÀ°úÀÇ Çù¾÷(Çѵ¶ÀÓÁ÷¿ø ºÀ»ç´Ü HiºÀ»ç´Ü ¿î¿µ)
|
Áö¿øÀÚ°Ý |
- ÃÑ °æ·Â 7³â ÀÌ»ó
- Àç´Ü¹ýÀÎ ±Ù¹«°æ·Â ÀÖ´Â ºÐ
- ¹Ú¹°°ü/¹Ì¼ú°ü °ü·Ã ¾÷¹« À¯°æÇèÀÚ ¿ì´ë (Çп¹¿¬±¸»ç ÀÚ°ÝÁõ ¼ÒÁöÀÚ ¿ì´ë)
- Àü½Ã ¹× °ø¿¬±âȹ ¿î¿µ À¯°æÇèÀÚ ¿ì´ë
- ¿îÀü°¡´ÉÀÚ ¿ì´ë
|